These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 24043904)
1. Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells. Terp MG; Olesen KA; Arnspang EC; Lund RR; Lagerholm BC; Ditzel HJ; Leth-Larsen R J Immunol; 2013 Oct; 191(8):4165-73. PubMed ID: 24043904 [TBL] [Abstract][Full Text] [Related]
2. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Stagg J; Divisekera U; Duret H; Sparwasser T; Teng MW; Darcy PK; Smyth MJ Cancer Res; 2011 Apr; 71(8):2892-900. PubMed ID: 21292811 [TBL] [Abstract][Full Text] [Related]
3. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs. Allard B; Pommey S; Smyth MJ; Stagg J Clin Cancer Res; 2013 Oct; 19(20):5626-35. PubMed ID: 23983257 [TBL] [Abstract][Full Text] [Related]
5. Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73. Yang X; Pei S; Wang H; Jin Y; Yu F; Zhou B; Zhang H; Zhang D; Lin D BMC Cancer; 2017 Apr; 17(1):255. PubMed ID: 28399915 [TBL] [Abstract][Full Text] [Related]
6. A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy. Qiao Z; Li X; Kang N; Yang Y; Chen C; Wu T; Zhao M; Liu Y; Ji X Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30823477 [TBL] [Abstract][Full Text] [Related]
7. RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. Zhi X; Chen S; Zhou P; Shao Z; Wang L; Ou Z; Yin L Clin Exp Metastasis; 2007; 24(6):439-48. PubMed ID: 17587186 [TBL] [Abstract][Full Text] [Related]
8. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis. Koszałka P; Gołuńska M; Stanisławowski M; Urban A; Stasiłojć G; Majewski M; Wierzbicki P; Składanowski AC; Bigda J Int J Biochem Cell Biol; 2015 Dec; 69():1-10. PubMed ID: 26545615 [TBL] [Abstract][Full Text] [Related]
9. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Fan Z; Masui H; Altas I; Mendelsohn J Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927 [TBL] [Abstract][Full Text] [Related]
10. Ecto-5'-nucleotidase activity is not required for T cell activation through CD73. Gutensohn W; Resta R; Misumi Y; Ikehara Y; Thompson LF Cell Immunol; 1995 Apr; 161(2):213-7. PubMed ID: 7697732 [TBL] [Abstract][Full Text] [Related]
11. CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy. Turcotte M; Allard D; Mittal D; Bareche Y; Buisseret L; José V; Pommey S; Delisle V; Loi S; Joensuu H; Kellokumpu-Lehtinen PL; Sotiriou C; Smyth MJ; Stagg J Cancer Res; 2017 Oct; 77(20):5652-5663. PubMed ID: 28855210 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of Ecto-5'-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix. Zhou P; Zhi X; Zhou T; Chen S; Li X; Wang L; Yin L; Shao Z; Ou Z Cancer Biol Ther; 2007 Mar; 6(3):426-31. PubMed ID: 17471030 [TBL] [Abstract][Full Text] [Related]
13. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice. Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599 [TBL] [Abstract][Full Text] [Related]
14. Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors. Beavis PA; Divisekera U; Paget C; Chow MT; John LB; Devaud C; Dwyer K; Stagg J; Smyth MJ; Darcy PK Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14711-6. PubMed ID: 23964122 [TBL] [Abstract][Full Text] [Related]
15. Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function. Jin R; Liu L; Xing Y; Meng T; Ma L; Pei J; Cong Y; Zhang X; Ren Z; Wang X; Shen J; Yu K Mol Cancer Ther; 2020 Nov; 19(11):2340-2352. PubMed ID: 32943546 [TBL] [Abstract][Full Text] [Related]
16. CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism. Airas L; Niemelä J; Jalkanen S J Immunol; 2000 Nov; 165(10):5411-7. PubMed ID: 11067892 [TBL] [Abstract][Full Text] [Related]
17. Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. Sadej R; Spychala J; Skladanowski AC Melanoma Res; 2006 Jun; 16(3):213-22. PubMed ID: 16718268 [TBL] [Abstract][Full Text] [Related]
18. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma. Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369 [TBL] [Abstract][Full Text] [Related]
19. Ecto-5'-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line. Andrade CM; Lopez PL; Noronha BT; Wink MR; Borojevic R; Margis R; Lenz G; Battastini AM; Guma FC Cell Tissue Res; 2011 May; 344(2):279-86. PubMed ID: 21424267 [TBL] [Abstract][Full Text] [Related]
20. Anti-CD73 therapy impairs tumor angiogenesis. Allard B; Turcotte M; Spring K; Pommey S; Royal I; Stagg J Int J Cancer; 2014 Mar; 134(6):1466-73. PubMed ID: 23982901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]